TransThera Sciences (Nanjing) Inc. (02617.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−9.5x

Market Cap

HKD 4.03B

MomentumView details →

1D Return

+0.59%

YTD Return

−91.17%

RSI (14)

39.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−9.5x

Market Cap

HKD 4.03B

RSI (14)

39.3

MomentumView details →

1D Return

+0.59%

YTD Return

−91.17%

ProfitabilityView details →

Gross Margin

87.74%

Net Margin

−767.30%

EBITDA Margin

−765.32%

ROE (TTM)

−30.56%

ROA (TTM)

−27.18%

Asset Turnover

0.04x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−10.14%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

HKD 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

8.82x

Quick Ratio

8.82x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

34.97M

Net Income (TTM)

−268.29M

Op. CF (TTM)

−144.48M

Latest newsMore news →

No recent news for 02617.HK.

Similar companies

Viking Therapeutics, Inc.VKTX 华恒生物688639.SH Telix Pharmaceuticals LimitedTLX Veradermics, IncorporatedMANE Iovance Biotherapeutics, Inc.IOVA Relay Therapeutics, Inc.RLAY Find similar companies →

Latest newsMore news →

No recent news for 02617.HK.